TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option

Q: What is the current NAV of TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option?

The latest NAV of TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option is ₹37.70 as of 2026-07-17.

Tata Mutual FundSectoral/ThematicVery High Risk

₹37.7-0.34 (-0.91%)

NAV as on 2026-07-17 · Equity · Sectoral/Thematic

AUM

₹1,455 Cr

1Y Return

+8.1%

3Y CAGR

+22.5%

5Y CAGR

+14.8%

Expense

0.67%

Risk

Very High

TATA India Pharma & Healthcare Fund Direct Plan

₹37.7-0.91%

1Y Return

+8.1%

3Y CAGR

+22.5%

5Y CAGR

+14.8%

Since Inception

+13.3%

AI Fund Analysis

Get AI-powered verdict, strengths, risks, and SIP recommendations for this fund.

NAV History

Drag or scroll the chart to pan through history

52-Week NAV Range

₹32.8

₹38.05

93% from 52W low

Fund Information

Sectoral/ThematicEquitySince 29-12-2015

Fund House

Tata Mutual Fund

Portfolio Composition

Asset Allocation

Equity97.5%

Cash2.5%

Market Cap Split

Large Cap24.0%

Mid Cap33.9%

Small Cap38.5%

Top Holdings

40 stocks

Weight1M Change

Sun Pharmaceuticals Industries Ltd

Healthcare

9.87%0.0%

Divi's Laboratories Ltd

Healthcare

5.92%0.0%

HealthCare Global Enterprises Ltd

Healthcare

5.45%0.0%

Abbott India Ltd

Healthcare

5.37%0.0%

Max Healthcare Institute Ltd Ordinary Shares

Healthcare

5.17%+5.1%

Cipla Ltd

Healthcare

5.07%+0.0%

Rainbow Childrens Medicare Ltd

Healthcare

4.23%0.0%

Apollo Hospitals Enterprise Ltd

Healthcare

4.06%0.0%

Mankind Pharma Ltd

Healthcare

3.73%+0.4%

Dr Reddy's Laboratories Ltd

Healthcare

3.73%+10.6%

Sector Allocation

Weight1M Change

Healthcare

93.7%+100%

Basic Materials

5.2%+20%

Financial Services

0.7%+17%

Fundamentals

P/E Ratio

40.60

Cat avg: 41.97

P/B Ratio

6.38

Cat avg: 5.98

Dividend Yield

1.00%

Cat avg: 0.61%

Price/Sale

5.95

Price/Cash Flow

30.04

Risk Metrics (3Y)

Sharpe Ratio

0.94

Cat avg: 0.98

Sortino Ratio

1.60

Cat avg: 1.71

Beta

1.00

Cat avg: 0.95

Std Deviation

16.76%

Cat avg: 16.29%

Peer Comparison

Fund	AUM (Cr)	Exp %	1Y	3Y	5Y
Tata India Pharma & Healthcare DirIDCW-R	1,455	0.67	+8.1%	+22.5%	+14.8%
Nippon India Pharma Dir Bns	9,044	0.79	+7.5%	+20.8%	+13.4%
ICICI Pru Pharma Healthcare Dg DirIDCW-P	6,625	0.86	+6.6%	+24.9%	+16.0%
SBI Healthcare Opportunities Dir IDCW-P	4,998	0.91	+14.8%	+24.7%	+17.4%
DSP Healthcare Fund Dir IDCW-P	3,514	0.51	+10.1%	+22.8%	+15.5%
Mirae Asset Healthcare Dir IDCW-P	3,253	0.44	+12.5%	+23.7%	+14.6%
HDFC Pharma and Healthcare Dir IDCW-P	2,611	1.08	+19.3%	-	-
Tata India Pharma & Healthcare DirIDCW-P	1,455	0.67	+8.1%	+22.5%	+14.8%
UTI Healthcare Dir IDCW-P	1,308	1.31	+12.7%	+26.4%	+15.4%
Aditya BSL Pharma & Hlthcare Dir IDCW-P	1,011	0.82	+14.5%	+23.1%	+14.0%

What If I Had Invested?

Investment Amount

₹

NAV history not available for this range

Key Metrics

AUM₹1,455 Cr

Expense Ratio0.67%

Volatility (3Y)16.8%

Sharpe Ratio0.94

Sortino Ratio1.60

Beta1.00

Min SIP₹500

Min Lumpsum₹5,000

Holdings36

Risk-o-Meter

Low

Moderate

High

Very High

Rated as Very High risk

Key Metrics

AUM₹1,455 Cr

Expense Ratio0.67%

Volatility (3Y)16.8%

Sharpe Ratio0.94

Sortino Ratio1.60

Beta1.00

Min SIP₹500

Min Lumpsum₹5,000

Holdings36

Risk-o-Meter

Low

Moderate

High

Very High

Rated as Very High risk

Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. NAV data sourced from AMFI. This is not SEBI-registered investment advice.